IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

Factor IX, Quantity: 3500 IU

Inapatikana kutoka:

CSL Behring Australia Pty Ltd

Dawa fomu:

Solution

Tungo:

Excipient Ingredients:

Njia ya uendeshaji:

Intravenous

Vitengo katika mfuko:

3500 IU

Dawa ya aina:

Not scheduled. Not considered by committee

Matibabu dalili:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Bidhaa muhtasari:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Registered

Idhini ya tarehe:

2020-11-19